High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma-Reference-Cited by-同舟云学术

High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma

Published:2016-07-07 Issue:1 Volume:9 Page:
ISSN:1757-2215
Container-title:Journal of Ovarian Research
language:en
Short-container-title:J Ovarian Res

Author:

Morales-Vásquez Flavia,Pedernera Enrique,Reynaga-Obregón Jesús,López-Basave Horacio Noé,Gómora María José,Carlón Elisa,Cárdenas Sandra,Silva-Ayala Raúl,Almaraz Miguel,Méndez Carmen

Funder

DGAPA UNAM

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13048-016-0247-6

Reference16 articles.

1. Bast Jr RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68:1331–7.

2. Yin BW, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: Identification as a new mucin, MUC16. J Biol Chem. 2001;276:27371–5.

3. Kabawat SE, Bast Jr RC, Bhan AK, Welch WR, Knapp RC, Colvin RB. Tissue distribution of a coelomic-epithelium related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol. 1983;2:275–85.

4. Jacobs I, Bast Jr RC. The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod. 1989;4:1–12.

5. Gupta D, Lis CG. Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature. J Ovarian Res. 2009;2:13.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of radiomics nomogram for metastatic status of epithelial ovarian cancer;Scientific Reports;2024-05-30

2. Investigating the efficacy of tissue factor pathway inhibitor‑2 as a promising prognostic marker for ovarian cancer;Oncology Letters;2024-05-08

3. A novel clinical nomogram for predicting cancer-specific survival in patients with non-serous epithelial ovarian cancer: A real-world analysis based on the Surveillance, Epidemiology, and End Results database and external validation in a tertiary center;Translational Oncology;2024-04

4. Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment;Frontiers in Drug Delivery;2024-02-01

5. Survival prognosis model for elderly women with epithelial ovarian cancer based on the SEER database;Frontiers in Oncology;2023-09-29